Pages
Products

AAV9-CAG-NLuc-2A-mCherry

For research use only. Not intended for any clinical use.

Cat. No. :   AAV00531Z

Serotype :   AAV Serotype 9 Storage :   -80 ℃

Titer: Size:

Inquire for Price

Virus Particles Information

Quality Control

Cat. No. AAV00531Z
Description AAV serotype 9 particles express 2A-linked NanoLuc Luciferase and mCherry reporter genes under the control of CAG promoter for neuronal specific expression.
Gene NLuc-2A-mCherry
Serotype AAV Serotype 9
Reporter mCherry, NLuc
Applications

1. Determination of optimal MOI (multiplicity of infection), administration methods etc.

2. Detection of the infection efficiency of the AAV serotype against a specific cell type or tissue.

3. Using reporter genes to visualize the distribution and expression of AAV vectors in live animals, helping assess the biodistribution and persistence of gene delivery.

Titer Varies lot by lot, typically ≥1x10^12 GC/mL
Size Varies lot by lot, for example, 30 μL, 100 μL, 500 μL etc.
Storage Store at -80℃. Avoid multiple freeze/thaw cycles.
Shipping Frozen on dry ice
Summary Creative Biogene ensures high-quality AAV particles by optimizing and standardizing production protocols and performing stringent quality control (QC). The specific QC experiments performed vary between AAV particle lots.
Endotoxin Endotoxins, primarily derived from Gram-negative bacteria, can trigger adverse immune responses. Endotoxin contamination is a significant concern in the production of AAV, especially for applications in animal studies and gene therapy. Effective endotoxin quality control is essential in the development and manufacturing of AAV particles. Creative Biogene utilizes rigorous endotoxin detection methods to monitor the endotoxin level in our produced AAV particles to ensure regulatory compliance.
Purity AAV purity is critical for ensuring the safety and efficacy of AAV-based applications.AAV capsids are composed of three main protein components, known as viral proteins: VP1, VP2, and VP3. These proteins play a critical role in the structure and functionality of the AAV capsid. Monitoring the VP1, VP2, and VP3 content in AAV preparations is essential for quality control in AAV production. Our AAV particles are tested for showing three clear bands of VP1, VP2 VP3 by SDS-PAGE.
Sterility The AAV virus samples are inoculated into the cell culture medium for about 5 days to detect bacterial and fungal growth.
Transducibility Upon requirement, Creative Biogene can perform in vitro or in vivo transduction assays to evaluate the ability of AAV to deliver genetic material into target cells or tissues, and assess gene expression and functional activities.
Empty vs. Full Capsids Based-on our proprietary AAV production and purification technology, Creative Biogene can always offer AAV particles with high ratio of full capsids. If required, we can also assess the ratio for a specifc lot of AAV particles by transmission electron microscopy (TEM) or other methods.
Quick Inquiry

Background

Q & A

Customer Reviews

AAV9-CAG-NLuc-2A-mCherry is a viral vector system that combines multiple advantages, making it particularly suitable for neuroscience research. This AAV serotype 9 vector exhibits excellent tropism for neuronal cells, enabling efficient transduction throughout the nervous system, including across the blood-brain barrier. The CAG hybrid promoter drives strong and sustained expression of dual reporter genes (NanoLuc luciferase and mCherry), while maintaining neuronal specificity. The inclusion of a 2A self-cleaving peptide ensures equimolar co-expression of both reporter genes without affecting the function of either protein. NanoLuc luciferase provides an extremely bright bioluminescent signal (100 times brighter than firefly luciferase), offering high sensitivity for quantitative analysis; while mCherry provides intuitive visual tracking and excellent photostability.

The AAV9-CAG-NLuc-2A-mCherry system has broad applications in neuroscience research and therapeutic development. It enables precise monitoring of neuronal activity patterns through bimodal imaging—combining sensitive bioluminescent detection and spatial fluorescent localization. Researchers utilize this vector construct to map neural circuits, track axonal transport, and study synaptic connections in vivo. The system is particularly valuable for longitudinal studies requiring repeated measurements, as the stability of NanoLuc allows for reliable signal detection over extended periods. In disease modeling, it aids in studying neurodegenerative processes, providing insights into disease mechanisms by correlating functional changes (via luciferase activity) and morphological changes (via mCherry fluorescence). This vector is an excellent platform for testing gene therapy approaches, with the reporter genes used to quantitatively assess transduction efficiency and transgene expression levels. Furthermore, the high brightness of the reporter genes makes high-throughput screening of neuroactive compounds in primary neuronal cultures possible.

Ask a Question

If your question is not addressed through these resources, you can fill out the online form below and we will answer your question as soon as possible.

Customer Reviews
Top-notch customer support

From inquiry to delivery, Creative Biogene's customer service was top-notch. Their team was knowledgeable, responsive, and ensured that our AAV9 vector met all of our research requirements.

Canada

Write a Review

Write a review of your use of Biogene products and services in your research. Your review can help your fellow researchers make informed purchasing decisions.

Needs improvement

Satisfaction

General satisfaction

Very satisfaction